The effects of cannabis on memory function in users with and without a psychotic disorder: Findings from a combined meta-analysis

Psychological Medicine

Volumn 46, Issue 1, 2016, Pages 177-188

  Schoeler, T ^a   Kambeitz, J ^a,b   Behlke, I ^a,c   Murray, R ^a   Bhattacharyya, S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

Cannabis; memory; meta analyses; psychosis; 9 tetrahydrocannabinol

Indexed keywords

CANNABINOID RECEPTOR AGONIST; DRONABINOL;

ADULT; CHEMICALLY INDUCED; DRUG EFFECTS; HUMAN; MEMORY; MEMORY DISORDER; META ANALYSIS; PATHOPHYSIOLOGY; PSYCHOSIS;

ADULT; CANNABINOID RECEPTOR AGONISTS; DRONABINOL; HUMANS; MEMORY; MEMORY DISORDERS; PSYCHOTIC DISORDERS;

EID: 84949535764     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291715001646     Document Type: Article

References (86)

1. Bahorik AL, Newhill CE, Eack SM (2013). Neurocognitive functioning of individuals with schizophrenia: using and not using drugs. Schizophrenia Bulletin 40, 856-867.
2. Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I, Gøtzsche PC, Lasserson T, Tovey D (2013). PRISMA for abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Medicine 10, e1001419.
3. Benedict RHB, Schretlen D, Groninger L, Brandt J (1998). Hopkins Verbal Learning Test-revised: normative data and analysis of inter-form and test-retest reliability. Clinical Neuropsychologist 12, 43-55.
4. Bhattacharyya S, Atakan Z, Martin-Santos R, Crippa JA, Kambeitz J, Prata D, Williams S, Brammer M, Collier DA, McGuire PK (2012). Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of 9-tetrahydrocannabinol on midbrain and striatal function. Molecular Psychiatry 17, 1152-1155.
5. Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O'Carroll C, Allen P, Seal ML, Fletcher PC, Crippa JA, Giampietro V,Mechelli A, Atakan Z,McGuire P (2009). Modulation of mediotemporal and ventrostriatal function in humans by 9-tetrahydrocannabinol: A neural basis for the effects of Cannabis sativa on learning and psychosis. Archives of General Psychiatry 66, 442-451.
6. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL (2002). Doserelated neurocognitive effects of marijuana use. Neurology 59, 1337-1343.
7. Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2011). Introduction to Meta-Analysis. Wiley: Chichester.
8. Bowman M, Pihl RO (1973). Cannabis: psychological effects of chronic heavy use. Psychopharmacologia 29, 159-170.
9. Bugra H, Studerus E, Rapp C, Tamagni C, Aston J, Borgwardt S, Riecher-Rössler A (2013). Cannabis use and cognitive functions in at-risk mental state and first episode psychosis. Psychopharmacology (Berlin) 230, 299-308.
10. Burt DB, Zembar MJ, Niederehe G (1995). Depression and memory impairment: A meta-analysis of the association, its pattern, and specificity. Psychological Bulletin 117, 285-305.
11. Carey KB, Carey MP, Simons JS (2003). Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning and psychiatric status. Journal of Nervous and Mental Disease 191, 300-308.
12. Cunha PJ, Rosa PGP, Ayres Ade M, Duran FLS, Santos LC, Scazufca M, Menezes PR, dos Santos B, Murray RM, Crippa JAS, Busatto GF, Schaufelberger MS (2013). Cannabis use, cognition and brain structure in first-episode psychosis. Schizophrenia Research 147, 209-215.
13. Curran VH, Brignell C, Fletcher S, Middleton P, Henry J (2002). Cognitive and subjective dose-response effects of acute oral 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berlin) 164, 61-70.
14. D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH (2005). 9-Tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biological Psychiatry 57, 594-608.
15. D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH (2004). The psychotomimetic effects of intravenous 9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29, 1558-1572.
16. Donoghue K, Doody GA (2012). Effect of illegal substance use on cognitive function in individuals with a psychotic disorder, a review and meta-analysis. Neuropsychology 26, 785-801.
17. Donoghue K, Mazzoncini R, Hart J, Zanelli J, Morgan C, Dazzan P, Morgan KD, Murray RM, Jones PB, Doody GA (2012). The differential effect of illicit drug use on cognitive function in first-episode psychosis and healthy controls. Acta Psychiatrica Scandinavica 125, 400-411.
18. Eichenbaum H (1993). Memory, Amnesia, and the Hippocampal System. The MIT Press: Cambridge, MA.
19. Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S, Stone JM, Reichenberg A, Brenneisen R, Holt D (2013). Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of Psychopharmacology 27, 19-27.
20. Ferraro L, Russo M, O'Connor J, Wiffen BDR, Falcone MA, Sideli L, Gardner-Sood P, Stilo S, Trotta A, Dazzan P, Mondelli V, Taylor H, Friedman B, Sallis H, La Cascia C, La Barbera D, David AS, Reichenberg A, Murray R, Di Forti M (2013). Cannabis users have higher premorbid IQ than other patients with first onset psychosis. Schizophrenia Research 150, 129-135.
21. Fletcher PC, Honey GD (2006). Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits. Trends in Cognitive Sciences 10, 167-174.
22. Fried PA, Watkinson B, Gray R (2005). Neurocognitive consequences of marihuana- A comparison with pre-drug performance. Neurotoxicology and Teratology 27, 231-239.
23. Gonzalez R, Carey C, Grant I (2002). Nonacute (residual) neuropsychological effects of cannabis use: A qualitative analysis and systematic review. Journal of Clinical Pharmacology 42 (11 Suppl.), 48S-57S.
24. Grant I, Gonzales R, Carey CL, Natarajan L, Wolfson T (2003). Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. Journal of the International Neuropsychological Society 9, 679-689.
25. Gruber SA, Sagar KA, Dahlgren MK, Racine M, Lukas SE (2012). Age of onset of marijuana use and executive function. Psychology of Addictive Behaviors 26, 496-506.
26. Hardwick S, King LA (2008). Home Office Cannabis Potency Study 2008. United Kingdom: Home Office Scientific Development Branch: St Albans.
27. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, De Costa BR, Rice KC (1990). Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences of the USA 87, 1932-1936.
28. Higgins JP, Green S (editors) (2008). Cochrane Handbook for Systematic Reviews of Interventions. Wiley Online Library: Chichester.
29. Hulicka IM (1966). Age differences in Wechsler Memory Scale scores. Journal of Genetic Psychology 109, 135-145.
30. Iversen L (2003). Cannabis and the brain. Brain 126, 1252-1270.
31. Jager G, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF (2006). Long-term effects of frequent cannabis use on working memory and attention: An fMRI study. Psychopharmacology (Berlin) 185, 358-368.
32. Jockers-Scherubl MC, Wolf T, Radzei N, Schlattmann P, Rentzsch J, Gomez-Carrillo de Castro A, Kuhl KP (2007). Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31, 1054-1063.
33. Kambeitz JP, Bhattacharyya S, Kambeitz-Ilankovic LM, Valli I, Collier DA, McGuire P (2012). Effect of BDNF val66met polymorphism on declarative memory and its neural substrate: A meta-analysis. Neuroscience and Biobehavioral Reviews 36, 2165-2177.
34. Kanayama G, Rogowska J, Pope HG, Gruber SA, Yurgelun-Todd DA (2004). Spatial working memory in heavy cannabis users: A functional magnetic resonance imaging study. Psychopharmacology (Berlin) 176, 239-247.
35. Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH (2010). Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Australian and New Zealand Journal of Psychiatry 44, 230-236.
36. Koskinen J, Löhönen J, Koponen H, Isohanni M, Miettunen J (2010). Rate of cannabis use disorders in clinical samples of patients with schizophrenia: A meta-analysis. Schizophrenia Bulletin 36, 1115-1130.
37. Lane SD, Cherek DR, Lieving LM, Tcheremissine OV (2005). Marijuana effects on human forgetting functions. Journal of the Experimental Analysis of Behavior 83, 67-83.
38. Leeson VC, Harrison I, Ron MA, Barnes TR, Joyce EM (2012). The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophrenia Bulletin 38, 873-880.
39. Linszen DH, Dingemans PM, Nugter MA, Van der Does AJ, Scholte WF, Lenior MA (1997). Patient attributes and expressed emotion as risk factors for psychotic relapse. Schizophrenia Bulletin 23, 119-130.
40. Løberg E-M, Hugdahl K (2009). Cannabis use and cognition in schizophrenia. Frontiers in Human Neuroscience 3, 53.
41. Løberg EM, Hugdahl K, Jørgensen HA (2008). Lower neurocognitive vulnerability in schizophrenia with a history of cannabis abuse? Schizophrenia Research 98, 73.
42. Lutgens D, Lepage M, Iyer S, Malla A (2014). Predictors of cognition in first episode psychosis. Schizophrenia Research 152, 164-169.
43. Matochik JA, Eldreth DA, Cadet JL, Bolla KI (2005). Altered brain tissue composition in heavy marijuana users. Drug and Alcohol Dependence 77, 23-30.
44. McDermott LM, Ebmeier KP (2009). A meta-analysis of depression severity and cognitive function. Journal of Affective Disorders 119, 1-8.
45. Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS, McDonald K, Ward A, Poulton R, Moffitt TE (2012). Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences of the USA 109, E2657-E2664.
46. Miles H, Johnson S, Amponsah-Afuwape S, Finch E, Leese M, Thornicroft G (2003). Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatric Services 54, 554-561.
47. Moreno-Granados JM, Ferrín M, Salcedo-Marín DM, Ruiz-Veguilla M (2014). Neuropsychological assessment of memory in child and adolescent first episode psychosis: cannabis and the paradox effect. Revista Brasileira de Psiquiatria 7, 13-24.
48. Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, Kapur S, Murray RM (2009). The acute effects of synthetic intravenous 9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychological Medicine 39, 1607-1616.
49. Moss HB, Chen CM, Yi HY (2013). Early adolescent patterns of alcohol, cigarettes, and marijuana polysubstance use and young adult substance use outcomes in a nationally representative sample. Drug and Alcohol Dependence 136, 51-62.
50. Murray RM, Lewis SW (1987). Is schizophrenia a neurodevelopmental disorder? British Medical Journal (Clinical Research ed.) 295, 681-682.
51. MurrayRM, Paparelli A,Morrison PD,Marconi A, Di FortiM (2013). What can we learn about schizophrenia from studying the human model, drug?induced psychosis? American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162B, 661-670.
52. Nakamura EM, Da Silva EA, Concilio GV, Adrian Wilkinson D, Masur J (1991). Reversible effects of acute and long-term administration of 9-tetrahydrocannabinol (THC) on memory in the rat. Drug and Alcohol Dependence 28, 167-175.
53. Packard MG, Knowlton BJ (2002). Learning and memory functions of the basal ganglia. Annual Review of Neuroscience 25, 563-593.
54. Pencer A, Addington J (2003). Substance use and cognition in early psychosis. Journal of Psychiatry and Neuroscience 28, 48-54.
55. Penk WE, Flannery RB Jr, Irvin E, Geller J, Fisher W, Hanson MA (2000). Characteristics of substance-abusing persons with schizophrenia: The paradox of the dually diagnosed. Journal of Addictive Diseases 19, 23-30.
56. Pertwee RG (2008). Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addiction Biology 13, 147-159.
57. Pezdek K, Evans GW (1979). Visual and verbal memory for objects and their spatial locations. Journal of Experimental Psychology Human Learning and Memory 5, 360-373.
58. Pope HG, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D (2003). Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug and Alcohol Dependence 69, 303-310.
59. Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D (2001). Neuropsychological performance in longtermcannabis users. Archives of General Psychiatry 58, 909-915.
60. Potvin S, Joyal CC, Pelletier J, Stip E (2008). Contradictory cognitive capacities among substance-abusing patients with schizophrenia: A meta-analysis. Schizophrenia Research 100, 242-251.
61. Poulsen HA, Sutherland GJ (2000). The potency of cannabis in New Zealand from 1976 to 1996. Science and Justice 40, 171-176.
62. Rabin RA, Zakzanis KK, Daskalakis ZJ, George TP (2012). Effects of cannabis use status on cognitive function, in males with schizophrenia. Psychiatry Research 206, 158-165.
63. Rabin RA, Zakzanis KK, George TP (2011). The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis. Schizophrenia Research 128, 111-116.
64. Ranganathan M, D'Souza DC (2006). The acute effects of cannabinoids on memory in humans: A review. Psychopharmacology 188, 425-444.
65. Ruiz-Veguilla M, Callado LF, Ferrin M (2012). Neurological soft signs in patients with psychosis and cannabis abuse: A systematic review and meta-analysis of paradox. Current Pharmaceutical Design 18, 5156-5164.
66. Salyers MP, Mueser KT (2001). Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophrenia Research 48, 109-123.
67. Schnell T, Koethe D, Daumann J, Gouzoulis-Mayfrank E (2009). The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology (Berlin) 205, 45-52.
68. Schoeler T, Bhattacharyya S (2013). The effect of cannabis use on memory function: An update. Journal of Substance Abuse and Rehabilitation 4, 11-27.
69. Schreiner AM, Dunn ME (2012). Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: A meta-analysis. Experimental and Clinical Psychopharmacology 20, 409-420.
70. Smith K, Flatley J (2011). Drug misuse declared: findings from the 2010/11 British Crime Survey England and Wales. Home Office Statistical Bulletin 12/11 (https://www.gov.uk/ government/uploads/system/uploads/attachment-data/file/ 116333/hosb1211.pdf). Accessed August 2015.
71. Smith MJ, Cobia DJ, Wang L, Alpert KI, Cronenwett WJ, Goldman MB, Mamah D, Barch DM, Breiter HC, Csernansky JG (2014). Cannabis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects. Schizophrenia Bulletin 40, 287-299.
72. Sneider JT, Pope HG Jr, Silveri MM, Simpson NS, Gruber SA, Yurgelun-Todd DA (2008). Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers. European Neuropsychopharmacology 18, 612-619.
73. Solowij N, Battisti R (2008). The chronic effects of cannabis on memory in humans: A review. Current Drug Abuse Reviews 1, 81-98.
74. Solowij N, Pesa N (2010). Cognitive abnormalities and cannabis use. Revista Brasileira de Psiquiatria 32 (Suppl. 1), S31-S40.
75. Song F, Sheldon TA, Sutton AJ, Abrams KR, Jones DR (2001). Methods for exploring heterogeneity in metaanalysis. Evaluation and the Health Professions 24, 126-151.
76. Soueif MI (1976). Differential association between chronic cannabis use and brain function deficits. Annals of the New York Academy of Sciences 282, 323-343.
77. Tait RJ, Mackinnon A, Christensen H (2011). Cannabis use and cognitive function: 8-year trajectory in a young adult cohort. Addiction 106, 2195-2203.
78. UN Office on Drugs and Crime (2010). World Drug Report 2010. United Nations Publications: New York.
79. Vakil E, Blachstein H (1997). Rey AVLT: developmental norms for adults and the sensitivity of different memory measures to age. Clinical Neuropsychologist 11, 356-369.
80. Viechtbauer W (2010). Conducting meta-analyses in R with the metafor package. Journal of Statistical Software 36, 1-48.
81. Wadsworth EJK, Moss SC, Simpson SA, Smith AP (2006). Cannabis use, cognitive performance and mood in a sample of workers. Journal of Psychopharmacology 20, 14-23.
82. Wagner D, Becker B, Gouzoulis-Mayfrank E, Daumann J (2010). Interactions between specific parameters of cannabis use and verbalmemory. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34, 871-876.
83. Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK (2013). Comorbid substance abuse in firstepisode schizophrenia: effects on cognition and psychopathology in the EUFEST study. Schizophrenia Research 147, 132-139.
84. Wojtalik JA, Barch DM (2014). An fMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia. Frontiers in Psychiatry 5, 1.
85. Yücel M, Bora E, Lubman DI, Solowij N, Brewer WJ, Cotton SM, Conus P, Takagi MJ, Fornito A, Wood SJ (2012). The impact of cannabis use on cognitive functioning in patients with schizophrenia: A meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin 38, 316-330.
86. Yucel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, Lubman DI (2008). Regional brain abnormalities associated with long-term heavy cannabis use. Archives of General Psychiatry 65, 694-701.